The panel analyzes 163 genes associated with more than 100 medically actionable conditions, including cancer and cardiovascular disease.
Labcorp announced the launch of the Marker by Labcorp Genetic Health Panel, a service designed to help consumers understand inherited risks for more than 100 medically actionable health conditions, according to a company press release.
The panel, which will be available starting Aug 3, 2026, analyzes 163 genes associated with hereditary cancer, cardiovascular conditions, and metabolic conditions. The offering includes access to licensed genetic counselors to help users interpret results and determine next steps.
Research shows that nearly one in six adults who undergo genetic testing discover a variant linked to a serious and medically actionable health condition, according to Labcorp.
“Genetic information can play an important role in identifying health risks before symptoms appear, yet millions of people are unaware they carry an inherited genetic variant associated with an increased risk of serious disease,” says Leslie Saltzman, vice president of consumer health solutions at Labcorp, in a release. “The Marker by Labcorp Genetic Health Panel expands access to genetic health insights by combining genetic testing, genetic counseling support, and Labcorp’s genetics expertise into a single, convenient healthcare experience. Consumers can now access both biomarker and genetic testing through Labcorp OnDemand from a single source, supporting a more comprehensive approach to understanding their health.”
The testing process involves purchasing the panel through Labcorp OnDemand and scheduling a blood draw at one of the company’s patient service centers. Trained phlebotomists perform the specimen collection, and samples are sent to Labcorp laboratories for analysis.
Results are delivered through a secure patient portal and the MyLabcorp mobile platform. The final report includes identified findings and educational resources. Labcorp states that results are not diagnostic and should be considered alongside a person’s medical history, family history, and other risk factors.
The panel is supported by the company’s clinical genetic testing expertise and its Invitae genetic testing capabilities.
ID 111629049 © Jovanmandic | Dreamstime.com
